Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and Dapagliflozin Effects on Ketogenesis in T1D
NCT02777073Completed
- Sponsor
- University at Buffalo
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Liraglutide, Dapagliflozin and Placebo (3 arms). Primary endpoint: Difference in Ketone Bodies Formation (beta-hydroxybutyrate and acetoacetate) at 8 hours. Started Mar 2016; status: completed.
02
Drugs
liraglutidedapagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02777073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777073.